CUFinder

Wanlu Du

Wanlu Du

University of Michigan

H-index: 12

North America-United States

Contact Wanlu Du

About Wanlu Du

Wanlu Du, With an exceptional h-index of 12 and a recent h-index of 11 (since 2020), a distinguished researcher at University of Michigan,

His recent articles reflect a diverse array of research interests and contributions to the field:

Parkinson’s disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes

A protocol to measure lysosomal Zn2+ release through a genetically encoded Zn2+ indicator

Anti-EGFR VHH-armed death receptor ligand-engineered stem cells have therapeutic efficacy in basal-like breast cancer brain metastasis

Lysosomal Zn2+ release triggers rapid, mitochondria-mediated, non-apoptotic cell death in metastatic melanoma

Next-generation immunotherapies for brain metastatic cancers

OTHR-02. Engineered “of the shelf” allogeneic cellular therapies for metastatic brain tumors

Anti-EGFR VHH-armed death receptor ligand–engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers

Wanlu Du Information

University

Position

___

Citations(all)

1039

Citations(since 2020)

505

Cited By

719

hIndex(all)

12

hIndex(since 2020)

11

i10Index(all)

13

i10Index(since 2020)

12

Email

University Profile Page

Google Scholar

Top articles of Wanlu Du

Parkinson’s disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes

Cell

2022/6/23

Ping Li
Ping Li

H-Index: 5

Ce Wang
Ce Wang

H-Index: 13

Wei Chen
Wei Chen

H-Index: 15

Wenlong Zhang
Wenlong Zhang

H-Index: 5

Joel Swanson
Joel Swanson

H-Index: 37

Wanlu Du
Wanlu Du

H-Index: 10

Haoxing Xu
Haoxing Xu

H-Index: 42

A protocol to measure lysosomal Zn2+ release through a genetically encoded Zn2+ indicator

STAR protocols

2022/6/17

Haoxing Xu
Haoxing Xu

H-Index: 42

Yan Qin
Yan Qin

H-Index: 6

Wanlu Du
Wanlu Du

H-Index: 10

Anti-EGFR VHH-armed death receptor ligand-engineered stem cells have therapeutic efficacy in basal-like breast cancer brain metastasis

Brain Tumor Research and Treatment

2022/3/15

Susana Moleirinho
Susana Moleirinho

H-Index: 8

Wanlu Du
Wanlu Du

H-Index: 10

Khalid Shah
Khalid Shah

H-Index: 34

Lysosomal Zn2+ release triggers rapid, mitochondria-mediated, non-apoptotic cell death in metastatic melanoma

Cell Reports

2021/10/19

Wanlu Du
Wanlu Du

H-Index: 10

Wei Chen
Wei Chen

H-Index: 15

Michael Ryan
Michael Ryan

H-Index: 1

Haoxing Xu
Haoxing Xu

H-Index: 42

Next-generation immunotherapies for brain metastatic cancers

2021/9/1

Wanlu Du
Wanlu Du

H-Index: 10

Khalid Shah
Khalid Shah

H-Index: 34

OTHR-02. Engineered “of the shelf” allogeneic cellular therapies for metastatic brain tumors

Neuro-oncology Advances

2021/8

Khalid Shah
Khalid Shah

H-Index: 34

Wanlu Du
Wanlu Du

H-Index: 10

Anti-EGFR VHH-armed death receptor ligand–engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers

Science Advances

2021/3/3

Susana Moleirinho
Susana Moleirinho

H-Index: 8

Wanlu Du
Wanlu Du

H-Index: 10

Khalid Shah
Khalid Shah

H-Index: 34

See List of Professors in Wanlu Du University(University of Michigan)